Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.23.1
Cover - shares
 6 Months Ended
Apr. 30, 2023
Jun. 14, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Apr. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --10-31  
Entity File Number 001-37492  
Entity Registrant Name ANIXA BIOSCIENCES, INC.  
Entity Central Index Key 0000715446  
Entity Tax Identification Number 11-2622630  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 3150 Almaden Expressway  
Entity Address, Address Line Two Suite 250  
Entity Address, City or Town San Jose  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95118  
City Area Code (408)  
Local Phone Number 708-9808  
Title of 12(b) Security Common Stock, par value $.01 per share  
Trading Symbol ANIX  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   30,975,703